Seres Therapeutics Inc

MCRB

$30.16

+756.93% (1 year change)

Avg closing price

Price range

Market Cap

$2.65 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

-

Total revenue in the last quarter.

Net Income

$-20.7 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$-1.07

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

-

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-28.3x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-20.5 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

108

The number of full time employees.

Revenue & Earnings

Balance Sheet

Seres Therapeutics Inc

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

News

BidaskClub Downgrades Seres Therapeutics (NASDAQ:MCRB) to Hold

BidaskClub Downgrades Seres Therapeutics (NASDAQ:MCRB) to Hold

Seres Therapeutics (NASDAQ:MCRB) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Thursday, BidAskClub reports. MCRB has be...

 Dakota Financial News Dakota Financial News, 1 day ago
Seres Therapeutics (NASDAQ:MCRB) Shares Down 10.8%

Seres Therapeutics (NASDAQ:MCRB) Shares Down 10.8%

Seres Therapeutics Inc (NASDAQ:MCRB)’s stock price fell 10.8% during trading on Wednesday . The company traded as low as $28.11 and last traded at $28.20. 635,648 shares were traded during mid-day ...

The Olympia Report The Olympia Report, 4 days ago
Seres Therapeutics to Present at Upcoming Investor Conferences

Seres Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced that management will present at two upcoming investor conferences: H.C. Wainwright 22nd Annual Global Inves...

Business Wire Business Wire, about 1 month ago